Recombinant human interleukin-3 in refractory severe aplastic anaemia: a phase I/II trial-Reference-Cited by-同舟云学术

Recombinant human interleukin-3 in refractory severe aplastic anaemia: a phase I/II trial

Published:1995-10 Issue:2 Volume:91 Page:306-312
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Bargetzi Mario J.,Gldckman Eliane,Tichelli Andre,Devergie Agnes,Esperou Helene,Kabata Janusz,Wodnar-Filipowicz Alexandra,Nissen Catherine,Speck Bruno,Gratwohl Alois

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1995.tb05294.x/fullpdf

Reference34 articles.

1. Phase I/II study of recombinant human granulocyte-macrophage colony- stimulating factor in aplastic anemia and myelodysplastic syndrome

2. Antilymphocyte globulin, cyclosporin, and granulocyte colony- stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party

3. Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor.

4. Antithymocyte Globulin Treatment in Patients with Aplastic Anemia

5. Human IL-3 and GM-CSF Act Synergistically in Stimulating Hematopoiesis in Primates

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Growth Factor Therapy for Myelodysplastic Syndromes and Aplastic Anemia;Hematopoietic Growth Factors in Oncology;2004

2. The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) on megakaryopoiesis in patients with aplastic anaemia;British Journal of Haematology;1999-01

3. Cytokines for the Treatment of Myelodysplastic Syndromes and Other Bone Marrow Failure States;Clinical Applications of Cytokines and Growth Factors;1999

4. Thrombopoietic factors potentially useful in the treatment of acute leukemia;Leukemia Research;1998-12

5. Dyskeratosis Congenita: Multisystemic Disorder with Special Consideration of Immunologic Aspects;Clinical Pediatrics;1998-09